Stockreport

Evolus Announces Results from European Head-to-Head Filler Trial

Evolus, Inc.  (EOLS) 
Last evolus, inc. earnings: 2/25 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: us.evolis.com/investor-relations
PDF Evolus dermal filler product (Evolysse™/Estyme® Lift) demonstrates statistical superiority at 3 and 6 months compared to Restylane-L with respect to improvement in nasol [Read more]